Chordia Therapeutics Inc. (JP:190A) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chordia Therapeutics Inc. is committed to launching innovative drugs with novel mechanisms of action, aiming for sustainable sales and growth. The company emphasizes strong corporate governance to enhance trust and adapt to changing business environments, with Takeda Pharmaceutical Company Limited as its largest shareholder. Despite being a small player in the pharmaceutical sector, Chordia is listed on the Growth Market and is focused on strengthening its organizational structure for long-term success.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.